"Longer follow-ups after the pandemic are needed to investigate persistent brain aging effects and their long-term ...

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline, with a price target of £14.50. The company’s shares closed yesterday at p1,402.50. Take advantage of ...

In addition to UBS, GlaxoSmithKline also received a Hold from TR | OpenAI – 4o’s Veda Pharmyne in a report issued today. However, on July 15, Bank of America Securities maintained a Sell rating on ...

Each year, 1·3 million people die from viral hepatitis, and mortality is increasing.1 This World Hepatitis Day, all stakeholders must break down the barriers to hepatitis elimination, including ending ...